Preclinical Development of Low Toxicity Drugs: Focus on Zanamivir, an Anti-Influenza Drug

Author： Dines G.D.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.19, Iss.3, 1998-09, pp. : 233-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent advances in the discovery and development of anti-influenza drugs

By Wang Gary T  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 845-861

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in the discovery and development of anti-influenza drugs

By Klumpp Klaus  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 8, 2004-08 ,pp. : 1153-1168

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in pharmacophore modeling and its application to anti-influenza drug discovery

By Shin Woo-Jin   Seong Baik Lin  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 4, 2013-04 ,pp. : 411-426

Informa Healthcare

Access to resources Recommend Favorite

An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs

By Phan Viet Hong   Tan Cindy   Rittau Anneliese   Xu Hongmei   McLachlan Andrew J   Clarke Stephen J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1395-1410

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Computer-Aided Drug Design as Applied to Anti-Influenza Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 16, 2014-08 ,pp. : 1875-1889

Bentham Science Publishers

Access to resources Recommend Favorite